(Q35095916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Vincenzo La Mura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ferdinando Carlo Sasso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Marco Romano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Giuseppe Signoriello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Marcello Persico

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

8

Fabiana Perna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2

Amalia De Renzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Valerio Rosato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Fabrizio Pane

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

17 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/1471-230x-14-31

8 March 2020

exact match

0 references

cites work

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Prevalence of occult hepatitis B virus infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Chronic hepatitis B: update 2009

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Hepatitis B virus infection and transfusion medicine: science and the occult

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Prophylaxis and treatment of hepatitis B in immunocompromised patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Occult hepatitis B virus infection in a North American community-based population

9 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Occult hepatitis B virus in liver tissue of individuals without hepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

RETRACTED: Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938973

Occult hepatitis B virus infection

27 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-14-31

HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting

21 January 2018

1 reference

12 December 2020

Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings

1 reference

12 December 2020

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis

1 reference

12 December 2020

Principles of the revised European-American Lymphoma Classification (from the International Lymphoma Study Group)

1 reference

12 December 2020

Detection and quantitation of HBV DNA by semi-nested PCR in donated blood: comparison with HBV serological markers

1 reference

12 December 2020

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-14-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533834%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

PubMed publication ID

24533834

1 reference